Jun Xiao
Impact in
- Ophthalmology top 2%
- Ocular Diseases and Behçet’s Syndrome
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
- Neurology 14
- Neuroinflammation and Neurodegeneration Mechanisms 6
- Peripheral Neuropathies and Disorders 6
- Autoimmune Neurological Disorders and Treatments 4
- Long-Term Effects of COVID-19 3
- Co-authors
- Qiu Zhao (2 shared papers)Yafei Zhang (1 shared paper)Liang Zheng (2 shared papers)Lan Liu (1 shared paper)Mengya Zhao (1 shared paper)Xiaoli Liu (1 shared paper)Guanfang Su (1 shared paper)Chuan Qin (20 shared papers)
- Journals
- Frontiers in Immunology (4 papers)Aging (3 papers)International Journal of Medical Sciences (2 papers)Journal of Neuroinflammation (2 papers)International Immunopharmacology (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Jun Xiao
65 papers receiving 2.0k citations
Jun Xiao's Hit Papers
Peers
Comparison fields: 5 of 136
- Ophthalmology 276
- Neurology 347
- Infectious Diseases 394
- Industrial and Manufacturing Engineering 123
- Water Science and Technology 194
Countries citing papers authored by Jun Xiao
This map shows the geographic impact of Jun Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Xiao more than expected).
Fields of papers citing papers by Jun Xiao
This network shows the impact of papers produced by Jun Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Xiao. The network helps show where Jun Xiao may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Liver impairment in COVID‐19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China Hit paper breakdown → | 2020 | 349 |
| 2 | 2016 | 240 | |
| 3 | Immunopathogenesis of Behcet's Disease Hit paper breakdown → | 2019 | 183 |
| 4 | 2011 | 103 | |
| 5 | 2020 | 97 | |
| 6 | 2023 | 93 | |
| 7 | 2021 | 76 | |
| 8 | 2010 | 75 | |
| 9 | 2017 | 59 | |
| 10 | 2015 | 50 | |
| 11 | 2020 | 43 | |
| 12 | 2024 | 42 | |
| 13 | 2023 | 41 | |
| 14 | 2021 | 33 | |
| 15 | 2018 | 31 | |
| 16 | 2024 | 30 | |
| 17 | 2014 | 30 | |
| 18 | 2021 | 26 | |
| 19 | 2021 | 24 | |
| 20 | 2013 | 21 |
About Jun Xiao
Jun Xiao is a scholar working on Molecular Biology, Neurology, Oncology, Immunology and Epidemiology, having authored 67 papers that have together received 2.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers), COVID-19 Clinical Research Studies (6 papers), Peripheral Neuropathies and Disorders (6 papers), Cancer, Hypoxia, and Metabolism (4 papers), T-cell and B-cell Immunology (4 papers), Autoimmune Neurological Disorders and Treatments (4 papers) and Long-Term Effects of COVID-19 (3 papers). The work is most often cited by research in Ophthalmology (276 citations), Neurology (347 citations), Infectious Diseases (394 citations), Industrial and Manufacturing Engineering (123 citations) and Water Science and Technology (194 citations). Jun Xiao has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Qiu Zhao, Yafei Zhang, Liang Zheng, Lan Liu, Mengya Zhao, Xiaoli Liu, Guanfang Su, Chuan Qin, Ke Shang and Dai‐Shi Tian. Their work appears in journals such as Frontiers in Immunology, Aging, International Journal of Medical Sciences, Journal of Neuroinflammation and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.